(2022) How To Code Hypercoagulable State ICD 10 – List With Codes & Guidelines

This article will outline the causes, symptoms, diagnosis, treatment and the ICD 10 CM code for Hypercoagulable State.

Hypercoagulable State ICD 10 Causes

Hypercoagulable State ICD 10 (blood clots) is the result of interactions between blood vessels, platelets and clotting factors. Coagulation factors VII and V circulate inactively in the blood to prevent clotting disorders when they are not necessary. Injuries of these factors bind to cells exposed to the vascular wall and trigger the activation of the clotting cascade.

This enables the subsequent activation of the remaining clotting factors, which leads to the formation of thrombin factor II. Thrombin is converted into fibrinogen (fibrin factor I) and forms a connected network that stabilizes the thrombosis stopper. Proteins C and S form a complex that inactivates factors V and VIII. The coagulation cascade is regulated by various anticoagulants to limit the formation of clots at the site of injury and to prevent them becoming too large.

On the other hand, antithrombin III reduces thrombin production and inactivates factor X. These diseases are caused by an imbalance between thrombogenic and antithrosargic mechanisms, which puts sufferers at an increased risk of becoming hypercoagulable.

Hypercoagulable State ICD 10 Symptoms

Hypercoagulable State ICD 10, or blood clots, can reach many places, including the heart, lungs, brain, legs and kidneys. A patient’s symptoms depend on where the clot forms and how far it moves.

Symptoms include:

• chest pain
• shortness of breath
• upper body discomfort, including chest, neck and arms
• A blood clot in the heart or the lungs can cause a heart attack (pulmonary embolism, so-called because the blood clots the lungs )
• headaches
• speech problems
• dizziness
• paralysis on one or both sides of the body
• Blood clots in the brain can cause a stroke
• Blood clots in the lower body can be caused by deep vein thrombosis (blood clots in the legs) or peripheral artery disease (arteries narrowing). Symptoms can occur on the legs and include pain, redness, warmth and swelling.
• A blood clot in a vein in one of the kidneys can cause kidney failure. Symptoms may include less urination than usual, lower back pain and blood clots in the lungs.

Hypercoagulable State ICD 10 Diagnosis

Certain conditions that increase the risk of developing a Hypercoagulable State ICD 10 do not indicate a genetically hypercoagulable condition. A careful assessment of the patient’s personal, family and medical history is required. If a patient has one of the listed diseases, a doctor may recommend a blood test to assess the condition. A patient is a candidate for the screening of Hypercoagulable State ICD 10 if he or she has a family history of abnormal blood clotting, abnormal blood clots at a young age (under 50 years of age), thrombosis in an unusual place or location (such as a vein in the arm, liver, portal intestine, mesenteric kidney, kidney, brain or cerebral clot) that may occur without a clear cause, an idi.

These tests are carried out by specialised coagulation laboratories and interpreted by pathologists or doctors with expertise in coagulation, vascular medicine or hematology. Common laboratory tests include the PT-INR and Prothrombin Time (PT-protime) tests used to calculate the international normalized ratio (INR). These tests should be performed even if the patient did not have an acute clotting event.

This information is used to monitor the condition while taking warfarin or coumadin. Your INR helps the healthcare provider determine whether clots are still present and whether the dose of warfarin / coumadin needs to be changed. The activated partial thromboplastin time (APTT) measures the time it takes for the blood to clot. This test is used to monitor the disease in patients taking heparin.

Tests used to diagnose a hereditary Hypercoagulable State ICD 10 condition include genetic tests, including factor V resistance (Leiden activated protein-C) and the prothrombin gene mutation G20210A, antithrombin activity, protein C activity and protein activity, rapid plasma homocysteine levels and factor V. This gene mutation identifies genetic defects that increase the risk of blood clotting. Diagnostic tests help to detect antiphospholipid antibody syndrome and dysfibrinogenesis, conditions associated with hypercoaxial state. These tests include fibrinogenic values and complete blood count (CBC).

This test can help identify patients who are at risk of blood clotting and help determine the appropriate course and duration of treatment to prevent future clots. It can also help to identify relatives who may not have symptoms but may be at risk.

Hypercoagulable State ICD 10 Treatment

Hypercoagulable State ICD 10 can be treated with medication, but clots can also be dangerous for patients who need emergency treatment. Depending on the size and location of the clots, these patients may also receive routine treatment.

During emergency treatment, blood clots can damage the body and lead to serious problems such as stroke, heart disease, kidney failure, deep vein thrombosis and pulmonary embolism. They can also cause miscarriages, stillbirths and pregnancy-related problems. Emergency treatment to prevent these problems involves drugs called thrombolytic clot-busters to dissolve the clot.

These drugs can cause sudden bleeding and, in life-threatening situations, dissolve large blood clots. In non-emergency situations, anticoagulants [PDF] or blood thinners are used to prevent existing clots from getting larger and new clots forming. Blood thinners can be taken as tablets, injections through the skin, or with a needle or tube inserted into a vein (so-called intravenous (IV) injection).

Heparin is administered either by injection or through an IV tube. Warfarin is given in tablet form (coumadin (r), the most common brand name for the drug). Healthcare providers can treat patients simultaneously with heparin and warfarin.

Warfarin can take several days to start working. Once it starts to work, heparin can stop.

Other treatments Short-term treatments include antithrombin factor and protein C. Antithrombin factor is used for people who know there is an antithrombin deficiency and is also used in special situations like after surgery or in case of a severe blood clot or repeated blood clots. Some people with antithronbin deficiency need the antihormone factor because heparin does not work for them. Protein C is given to people with protein C deficiency when they receive warfarin. It is usually given to protect them from skin necrosis, a serious side effect of the drug that destroys or damages skin cells.

ICD 10 Code For Hypercoagulable State

ICD 10 CM 289.82 Secondary hypercoagulable state
ICD 10 CM D68.69 Other thrombophilia
ICD 10 CM D68.59 Other primary thrombophilia

Applicable To:

• Antithrombin III deficiency
• Hypercoagulable state NOS
• Primary hypercoagulable state NEC
• Primary thrombophilia NEC
• Protein C deficiency
• Protein S deficiency
• Thrombophilia NOS